Giant Biogene Holding Co., Ltd. (HKG:2367)
64.10
+1.10 (1.75%)
Sep 10, 2025, 2:02 PM HKT
Giant Biogene Holding Revenue
Giant Biogene Holding had revenue of 3.11B CNY in the half year ending June 30, 2025, with 93.85% growth. This brings the company's revenue in the last twelve months to 6.11B, up 37.05% year-over-year. In the year 2024, Giant Biogene Holding had annual revenue of 5.54B with 57.17% growth.
Revenue (ttm)
6.11B CNY
Revenue Growth
+37.05%
P/S Ratio
9.96
Revenue / Employee
3.48M CNY
Employees
1,758
Market Cap
66.69B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.54B | 2.01B | 57.17% |
Dec 31, 2023 | 3.52B | 1.16B | 49.05% |
Dec 31, 2022 | 2.36B | 811.96M | 52.30% |
Dec 31, 2021 | 1.55B | 362.01M | 30.41% |
Dec 31, 2020 | 1.19B | 233.78M | 24.44% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nongfu Spring | 50.78B |
MIXUE Group | 31.81B |
Smoore International Holdings | 13.95B |
Budweiser Brewing Company APAC | 46.97B |
WH Group | 212.22B |
China Resources Beer (Holdings) Company | 42.55B |
Tsingtao Brewery Company | 35.68B |
Want Want China Holdings | 25.21B |
Giant Biogene Holding News
- 3 months ago - Giant Biogene Bruised In A 'Battle Of The Skincare Belles' - Benzinga